Novo Nordisk A/S (NVO) — the earnings record

As of the 2026-11-03 card — updated after each print. An investment research diary, not advice.

The record at a glance

8/10EPS beats

8/10revenue beats

4 · 4 · 2up · flat · down (+3d, ±3%)

2026-11-04next print

Reactions across the covered prints span -5.3% to +9.9% — the beat column and the reaction column frequently disagree, which is the whole reason the record scores them separately. The street carries est revenue ~$11.07B (vendor) · expected Wednesday 4 November (date from data vendor, not yet confirmed by the company). Window from the report-day close, scored three sessions later. into the next print.

Print by print

Print	Date	EPS	Revenue
Aug 26	2026-08-05	✓ beat	✓ beat
May 26	2026-05-06	✓ beat	✓ beat
Feb 26	2026-02-03	✓ beat	✓ beat
Nov 25	2025-11-05	✓ beat	✗ miss
Aug 25	2025-08-06	✓ beat	✓ beat
May 25	2025-05-07	✗ miss	✓ beat
Feb 25	2025-02-05	✓ beat	✓ beat
Nov 24	2024-11-06	✓ beat	✓ beat
Aug 24	2024-08-07	✗ miss	✗ miss
May 24	2024-05-02	✓ beat	✓ beat

The per-print reaction chart, the load-bearing metric and the behavior read live on the full NVO print-record card — free registration.

FAQ · from the current data · as of 2026-11-03

Quick answers

How often does Novo Nordisk A/S beat earnings estimates?

Across the last 10 covered prints (as of the 2026-11-03 card), Novo Nordisk A/S beat EPS estimates 8 of 10 times and revenue estimates 8 of 10 times, with 7 double beats.

How does NVO stock react to earnings?

Measured close-of-print-day to the close three sessions later: 4 of the last 10 prints resolved up (beyond +3%), 4 flat, 2 down (as of the 2026-11-03 card) — reactions spanning -5.3% to +9.9%. Beat-or-miss and reaction are scored separately because they frequently disagree.

What was NVO's biggest earnings reaction?

+9.9% over the three sessions after the Aug 25 print (2025-08-06).

When does Novo Nordisk A/S report earnings next?

2026-11-04 (est EPS $0.73 · est revenue ~$11.07B (vendor) · expected Wednesday 4 November (date from data vendor, not yet confirmed by the company). Window from the report-day close, scored three sessions later.). The full print-record card — reaction chart, the load-bearing metric and the behavior read — updates after each print; registration is free. An investment research diary, not advice.

Related in the Closelooknet universe

same Closelooknet index seat first, then Drug Manufacturers - General. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.